Sudapyridine (WX-081) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

July 2, 2020

Study Completion Date

July 2, 2020

Conditions
Healthy
Interventions
DRUG

Sudapyridine 30mg

Sudapyridine capsule 30mg, orally, single dose

DRUG

Sudapyridine 100mg SAD

Sudapyridine tablet, 100mg orally, single dose

DRUG

Sudapyridine 200mg SAD

Sudapyridine tablet, 200mg orally, single dose

DRUG

Sudapyridine 200mg MAD

Sudapyridine tablet, 200mg orally once a day for 14 days

DRUG

Sudapyridine 300mg MAD

Sudapyridine tablet, 300mg orally once a day for 14 days

OTHER

Placebo tablet SAD

Placebo tablet, 100mg orally, single dose

OTHER

Placebo 200mg SAD

Placebo tablet, 200mg orally, single dose

OTHER

Placebo tablet MAD

Placebo tablet, 200mg orally once a day for 14 days

OTHER

Placebo tablet MAD

Placebo tablet, 300mg orally once a day for 14 days

Trial Locations (1)

Unknown

Shanghai Xuhui District Central Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Jiatan Pharmatech Co., Ltd

INDUSTRY

NCT06117514 - Sudapyridine (WX-081) in Healthy Volunteers | Biotech Hunter | Biotech Hunter